Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,411 EUR | +0,37% | +3,27% | -10,65% |
Omzet 2024 * | 4,4 mln. 4,69 mln. | Omzet 2025 * | 7,4 mln. 7,89 mln. | Marktkapitalisatie | 26,6 mln. 28,35 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -26 mln. -27,71 mln. | Nettowinst (verlies) 2025 * | -25 mln. -26,64 mln. | EV/omzet 2024 * | 19,2 x |
Nettoschuld 2024 * | 57,8 mln. 61,6 mln. | Nettoschuld 2025 * | 85,7 mln. 91,34 mln. | EV/omzet 2025 * | 15,2 x |
K/w-verhouding 2024 * |
-0,72
x | K/w-verhouding 2025 * |
-0,73
x | Werknemers | 23 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 64,4% |
Recentste transcriptie over GenSight Biologics S.A.
1 dag | +0,37% | ||
1 week | +3,27% | ||
Lopende maand | +2,24% | ||
1 maand | +2,49% | ||
3 maanden | +0,74% | ||
6 maanden | -34,87% | ||
Lopend jaar | -10,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 19-05-21 | |
Scott Jeffers
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-22 |
Magali Taiel
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Wyzga
CHM | Chairman | 69 | 01-10-13 |
José-Alain Sahel
FOU | Founder | 68 | 01-01-12 |
Cédric Moreau
BRD | Director/Board Member | 37 | 11-06-19 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 0,411 | +0,37% | 258 |
22-04-24 | 0,4095 | -0,12% | 26 841 |
19-04-24 | 0,41 | 0,00% | 21 651 |
18-04-24 | 0,41 | -2,84% | 55 094 |
17-04-24 | 0,422 | +6,03% | 89 644 |
Real Time Euronext Paris, 23 april 2024 om 09:17 uur
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,65% | 28,32 mln. | |
+2,49% | 96,73 mld. | |
-0,58% | 21,31 mld. | |
-16,61% | 21,21 mld. | |
-5,20% | 18,79 mld. | |
-42,14% | 16,37 mld. | |
-27,40% | 13,68 mld. | |
+1,44% | 13,44 mld. | |
+21,29% | 10,98 mld. | |
-21,79% | 8,56 mld. |